Recent deaths halt intense drug therapy to lower blood sugar
There is a recent report that 257 patients have died after receiving intense therapy to lower their blood sugar. As a result, the National Institutes of Health has discontinued a portion of major study on diabetes and heart disease. The study was aimed at reducing to normal levels the blood sugar of type 2 diabetics at especially high risk of heart attack and stroke.
It is important to note that NHLBI officials stressed that they have been unable to link the increased deaths in the study to any drug, including Avandia. There are over 18 million Americans that have been diagnosed as having diabetes, with type 2 the most common form.
Click here to read more from the Associated Press and MSNBC on the recent deaths from dug intense therapy to lower blood sugar.
